IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

Filer	Shares	Latest Filing Date	Previously owned	Change	Share-Type	Market Value
Northpond Ventures, Llc	8.81M	2022-11-14	8.81M	0	Shares	15.15M
Yale University	0	2022-08-12	93.56K	-93.56K	Shares	0

NASDAQ:ISO

IsoPlexis Corporation

Last Close

0.76

20/03 20:00

Market Cap

30.28M

Beta: -

Volume Today

111.02K

Avg: 47.29K

PE Ratio

−0.27

PFCF: −0.29

Institutional trades

Institutional Ownership

Current holdings institutionals